FDA issues guidance on generic versions of complex drugs

11-10-2018

FDA issues guidance on generic versions of complex drugs

ca-ssis / iStockphoto.com

The US Food and Drug Administration (FDA) has released guidance intended to advance the development of generic versions of complex medical drugs.


US Food and Drug Administration, Scott Gottlieb, complex drugs, generic competition, Abbreviated New Drug Application, topical delivery systems

LSIPR